Filters
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
Mayo Clinic Laboratories Mayo Clinic United States | 5 | 5 |
|
Spinocerebellar Ataxia Panel (SCA1,2,3,6, and 7) Center for Genetics at Saint Francis Saint Francis Hospital United States | 5 | 5 |
|
SCA Panel (SCA1, 2, 3, 6, 7) test Neurogenetics Department Cyprus Institute of Neurology and Genetics Cyprus | 5 | 5 |
|
Ataxin 3 (ATXN3) gene CAG triplet repeat test Neurogenetics Department Cyprus Institute of Neurology and Genetics Cyprus | 1 | 1 |
|
Ataxia / Spastic Paraplegia Comprehensive Panel Centogene US, LLC - The Rare Disease Company United States | 451 | 452 |
|
Centogene US, LLC - The Rare Disease Company United States | 13 | 13 |
|
ATXN3 - Repeat expansion analysis Centogene US, LLC - The Rare Disease Company United States | 1 | 1 |
|
ATXN3 - Repeat expansion analysis Centogene AG - the Rare Disease Company Germany | 1 | 1 |
|
Ataxia / Spastic Paraplegia Comprehensive Panel Centogene AG - the Rare Disease Company Germany | 451 | 452 |
|
Centogene AG - the Rare Disease Company Germany | 13 | 13 |
|
Machado-Joseph Disease (MJD)/Spinocerebellar Ataxia Type 3 (SCA3) via the ATXN3 CAG Repeat Expansion PreventionGenetics United States | 1 | 1 |
|
Intergen Genetic Diagnosis and Research Centre Turkey | 1 | 1 |
|
Intergen Genetic Diagnosis and Research Centre Turkey | 1 | 1 |
|
Genomic UnityⓇ Ataxia Repeat Expansion Analysis (STR analysis of 12 loci) Variantyx, Inc. United States | 12 | 12 |
|
Genomic UnityⓇ Comprehensive Ataxia Analysis (includes STR analysis of 12 loci) Variantyx, Inc. United States | 52 | 52 |
|
Spinocerebellar ataxia type 3 presymptomatic testing Genetics Service Unit National Institute of Biomedical Genomics India | 1 | 1 |
|
Genetics Service Unit National Institute of Biomedical Genomics India | 1 | 1 |
|
Genetic Services Laboratory University of Chicago United States | 13 | 13 |
|
ATXN3. CAG expansion detection by PCR IGENOMIX Spain | 1 | 1 |
|
IGENOMIX Spain | 6 | 5 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.